BIRC5 and nonpapillary renal cell carcinoma: To overcome this limitation, we analyzed TCGA data for ccRCC, pRCC, and chRCC and found that BIRC5 was significantly increased in tumors of the three major tumor subtypes compared with non-tumor tissues and that elevated expression correlated with tumor progression.